- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 17-04-2026: Press Release
17-04-2026 | 10:40 am
17-04-2026 | 10:40 am
Aurobindo Pharma secured USFDA approval for Glycerol Phenylbutyrate Oral Liquid, targeting a US$ 5.02 Cr market. Immediate launch expected, bolstering its product portfolio.
No comments yet. Be the first to comment!